Company intelligence / Profile preview

Qool Therapeutics

Menlo Park, California, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Qool Therapeutics developed a proprietary, non-invasive temperature management system for rapid therapeutic hypothermia through pulmonary delivery of frozen saline particles, with preclinical and early product development efforts supported by $12M+ in funding and planned first-in-human trials as of late 2017. No public evidence of successful clinical trials or commercialization found through 2025.

Therapeutic areas: CardiovascularInfectious DiseasesNeurologyOtherDermatology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Defense Innovation Unit (U.S. DoD)

Beyond the preview

Go deeper on Qool Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qool Therapeutics.

Explore the full profile